Patients who developed hepatitis C-related hepatocellular carcinoma after achieving sustained virologic response with interferon-free direct-acting antivirals had a 60% to 70% improvement in 5-year survival compared with untreated patients.
The results of the study come from a retrospective global analysis that included patient data gathered from the U.S., Japan, South Korea and Taiwan between 2005 and 2017.
This activity is supported by an educational grant from Astellas Pharma Global Development, Inc.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.